Related Experiment Video
Updated: Mar 24, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an
Jarosław Biliński1, Paweł Grzesiowski2, Jacek Muszyński3
1Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Poland.
Abstract:
Colonization of the gastrointestinal tract with multidrug-resistant (MDR) bacteria is a consequence of gut dysbiosis. We describe the successful utilization of fecal microbiota transplantation to inhibit Klebsiella pneumoniae MBL(+) and Escherichia coli ESBL(+) gut colonization in the immunocompromised host as a novel tool in the battle against MDR microorganisms. ClinicalTrials.gov identifier NCT02461199.
Related Concept Videos
Functions of the Gut Microbiota
Microbiota of the Large Intestine
What is Monogastric Digestion?
Development of Human Microbiota
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Introduction to the Human Microbiota

